Skip to content

Serratus Posterior Superior Intekcostal Plane Block vs Serratus Anterior Plane Block for Postoperative Analgesia in VATS: A Randomized Trial

Comparison of the Analgesic Effects of Serratus Posterior Superior Intercostal Plane Block (SPSIPB) and Serratus Anterior Plane Block (SAPB) on Postoperative Analgesia in Video-Assisted Thoracoscopic Surgery (VATS)

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07020624
Enrollment
50
Registered
2025-06-13
Start date
2025-07-01
Completion date
2026-08-01
Last updated
2025-06-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Analgesia, Video Assisted Thoracoscopic Surgery

Keywords

serratus posterior superior intercostal plane block, Video-assisted thoracoscopic surgery, serratus anterior plane block

Brief summary

Thoracotomy is known as one of the most painful surgical procedures, with up to 65% of patients developing chronic post-thoracotomy pain syndrome (PTPS), and approximately 10% experiencing pain that significantly impacts quality of life. Video-assisted thoracoscopic surgery (VATS) has become increasingly common over the past decade and offers reduced postoperative pain, morbidity, and length of hospital stay compared to open thoracotomy. However, VATS can still cause moderate to severe postoperative pain and a high risk of chronic pain. Optimizing analgesia after VATS remains critical. With advances in ultrasound technology, several regional anesthesia techniques such as serratus anterior plane block (SAPB), erector spinae plane block (ESPB), and thoracic epidural analgesia (TEA) have shown comparable efficacy. In 2023, Tulgar et al. described the serratus posterior superior intercostal plane block (SPSIPB), which demonstrated dermatomal coverage from C3 to T10. This randomized controlled trial aims to compare the analgesic efficacy of SPSIPB and SAPB in patients undergoing VATS procedures.

Detailed description

The patients will be divided into two groups and all will receive general anesthesia. Before extubation, one group will receive a Serratus Anterior Plane Block, and the other group will receive a Serratus Posterior Superior Intercostal Plane Block. The randomization of the study will be performed by a physician who will not be involved in the patient follow-up, using a computer-generated randomization code (generated by the computer). The interfascial plane block (Serratus Anterior Plane Block or Serratus Posterior Superior Intercostal Plane Block) will be given to the anesthesiologist in a sealed envelope by an independent assistant personnel outside the study. The patient will not be aware of which block is being applied. The anesthesiologist performing the block will not participate in the patients' pain monitoring. Postoperative pain assessment and data collection will be performed by another anesthesiologist who is unaware of the study. For standardization purposes, the block procedure will be performed by an experienced anesthesiologist who has performed at least 20 successful and uncomplicated procedures before.

Interventions

OTHERSAPB

Ultrasound guided serratus anterior plane block will be performed.

OTHERSPSIPB

Ultrasound guided serratus posterior superior intercostal plane block will be performed.

Sponsors

Samsun University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Masking description

The anesthetist who will perform the blocks will not participate in the pain follow-up of the patients. Postoperative pain assessment and data collection will be performed by another anesthetist blinded to the study.

Intervention model description

two interventional group

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* BMI \< 35 kg/m² Patients with ASA scores I, II, III

Exclusion criteria

* Patients who do not want to be included in the study Psychiatric and neurological disease with blurred consciousness Patients with ASA \> 3 BMI \> 35 kg/m² Abnormality in coagulation parameters History of allergy to local anesthetic drugs Infection at the injection site Patients whose surgical procedure time exceeds 150 minutes

Design outcomes

Primary

MeasureTime frameDescription
Morphine consumption in the first 24 hours postoperativelyup to 24 hoursMorfin consumption in the first 24 hours after surgery

Secondary

MeasureTime frameDescription
Pain densityup to 24 hours.NRS scores (Numeric rating scale; 0: no pain, 10: severe pain) in the first 24 hours after surgery
Quality of recovery24 hours after surgeryQR15 scores
Nausea and vomitingup to 24 hoursNausea and vomiting scores in the first 24 hours (verbal rating scale; 0= none, 1= nausea, 2= gagging, 3= vomiting)
shoulder painup to 24 hourspostoperative shoulder pain;shoulder pain will be evaluated as present/absent

Countries

Turkey (Türkiye)

Contacts

Primary Contactgamze ertaş, specialist
gamzertas.md@hotmail.com5056587914
Backup Contacthamiyet şenol çakmak, specialist
hamiyetsenolcakmak@gmail.com3623111500

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026